Group One Trading’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.91K	Sell	200 -2,200	-92%	-$65.3K	﹤0.01%	6807
2025 Q4	$74.7K	Buy	2,400 +1,500	+167%	+$41.1K	﹤0.01%	5243
2025 Q3	$19.4K	Sell	900 -30,700	-97%	-$554K	﹤0.01%	6711
2025 Q2	$442K	Buy	31,600 +11,000	+53%	+$149K	﹤0.01%	3546
2025 Q1	$278K	Buy	20,600 +3,000	+17%	+$51.1K	﹤0.01%	3686
2024 Q4	$337K	Sell	17,600 -8,000	-31%	-$174K	﹤0.01%	3503
2024 Q3	$582K	Buy	25,600 +5,000	+24%	+$81.7K	﹤0.01%	2744
2024 Q2	$268K	Buy	20,600 +17,200	+506%	+$238K	﹤0.01%	3145
2024 Q1	$59.5K	Buy	3,400 +2,900	+580%	+$56.2K	﹤0.01%	4572
2023 Q4	$10.9K	Buy	500 +300	+150%	+$4.74K	﹤0.01%	6140
2023 Q3	$3.07K	Sell	200 -1,700	-89%	-$32.4K	﹤0.01%	6905
2023 Q2	$45.2K	Buy	1,900 +100	+6%	+$2.56K	﹤0.01%	5357
2023 Q1	$45.8K	Sell	1,800 -18,900	-91%	-$606K	﹤0.01%	4915
2022 Q4	$605K	Sell	20,700 -8,000	-28%	-$184K	﹤0.01%	2873
2022 Q3	$589K	Buy	+28,700	New	+$516K	﹤0.01%	3079
2022 Q2	–	Sell	-1,300	Closed	-$24K	–	8591
2022 Q1	$24K	Buy	+1,300	New	+$25K	﹤0.01%	6651